Inotropes and Vasopressors: An Update on Use in ICU Settings

Inotropes and vasopressors are essential pharmacological agents in the management of critically ill patients, particularly those experiencing shock. This review updates the use of these vasoactive medications in intensive care unit (ICU) settings, addressing their pharmacology, indications, and clinical efficacy. It covers commonly utilized inotropes such as dopamine, dobutamine, and milrinone, along with vasopressors like norepinephrine and vasopressin. The article discusses factors influencing the choice of therapy, including patient-specific variables, the underlying cause of shock, and real-time hemodynamic monitoring. Special emphasis is placed on the titration of doses to achieve optimal outcomes, minimize adverse effects, and avoid complications associated with prolonged use. Recent advancements in monitoring technologies and evolving evidence from randomized controlled trials are incorporated to provide a comprehensive overview of current practices and emerging strategies for vasoactive therapy in critical care. The review concludes with recommendations for personalized approaches to inotropic and vasopressor management in critically ill patients. This review aims to explore the role of inotropes and vasopressors in critical care, focusing on their mechanisms of action, therapeutic applications, and relevance in managing different forms of shock. Additionally, it highlights the importance of tailoring therapy to individual patient needs, discusses challenges associated with optimizing drug use, and examines emerging advancements in this field. By synthesizing current evidence, the article aims to provide healthcare professionals with valuable insights to enhance patient care in ICU settings.